Acorn Financial Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-764
Closed -$220K 209
2023
Q4
$220K Sell
764
-18
-2% -$4.9K 0.04% 231
2023
Q3
$210K Buy
+782
New +$195K 0.04% 231
2021
Q3
Sell
-1,051
Closed -$256K 213
2021
Q2
$256K Buy
1,051
+68
+7% +$16.7K 0.08% 210
2021
Q1
$245K Hold
983
0.09% 181
2020
Q4
$227K Hold
983
0.09% 203
2020
Q3
$250K Buy
983
+2
+0.2% +$495 0.13% 180
2020
Q2
$231K Sell
981
-118
-11% -$26.9K 0.16% 173
2020
Q1
$222K Sell
1,099
-21
-2% -$4.59K 0.22% 142
2019
Q4
$269K Buy
+1,120
New +$247K 0.23% 137

Other funds holding AMGN

Acorn Financial Advisory Services's AMGN Position: Q1 2024 in Review

Acorn Financial Advisory Services sold out of Amgen (AMGN) in Q1 2024, closing a stake of 764 shares — an estimated $220K sold.

Acorn Financial Advisory Services first reported a position in AMGN in Q4 2019 and held it in 9 quarters. The position peaked at $269K in Q4 2019. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Acorn Financial Advisory Services reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Acorn Financial Advisory Services sold 764 Amgen shares in Q1 2024, an estimated $220K.
  • Acorn Financial Advisory Services first reported a position in Amgen in Q4 2019 and held it in 9 quarters.
  • Acorn Financial Advisory Services's Amgen position peaked at $269K in Q4 2019.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Acorn Financial Advisory Services's 13F filing for Q1 2024, filed 8 May 2024.